|
Apr 10
|
Genmab A/S Share Capital Reduction
|
|
Apr 7
|
Transactions In Connection with Share Buy-back Program
|
|
Feb 24
|
Is Genmab (GMAB) One of the Best Growth Stocks to Invest In According to Analysts?
|
|
Feb 20
|
EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma
|
|
Feb 19
|
Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference
|
|
Feb 13
|
Why Genmab (GMAB) and Sonic Automotive (SAH) Are Advancing Today
|
|
Feb 13
|
Notice to Convene the Annual General Meeting of Genmab A/S
|
|
Feb 13
|
Genmab AS (GMAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ...
|
|
Feb 12
|
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
|
|
Feb 12
|
Genmab Publishes 2024 Annual Report
|
|
Oct 9
|
Genmab A/S (GMAB): Among The Stocks With Biggest Upside Potential According to Hedge Funds
|
|
Oct 8
|
GMAB or INCY: Which Is the Better Value Stock Right Now?
|
|
Oct 8
|
Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround
|
|
Sep 30
|
Is Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?
|
|
Aug 30
|
Genmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short Sellers
|
|
Aug 28
|
Top High Growth Tech Stocks To Watch In August 2024
|
|
Aug 26
|
Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
|
|
Aug 8
|
Genmab Announces Financial Results for the First Half of 2024
|
|
Aug 8
|
Genmab Updates 2024 Financial Guidance
|
|
Aug 5
|
BioNTech exits PD-L1 development with Genmab as Q2 revenues drop
|